UK Research and Innovation awards £45 million to EMBL’s European Bioinformatics Institute (EMBL-EBI)

Funding awarded for bioinformatics infrastructure

UK Research and Innovation (UKRI) has awarded £45 million to EMBL’s European Bioinformatics Institute (EMBL-EBI), to enhance the institute’s technical and building infrastructure. The funding, which comes from the UKRI’s Strategic Priorities Fund, will support EMBL-EBI’s existing and emerging data resources, including in areas of major interest, such as genomics and bioimaging.

READ MORE …

Minimap2 makes sophisticated analysis possible on hand-held devices

The Garvan Institute brings DNA analysis capabilities to smartphones

The Garvan Institute of Medical Research has partnered with the University of NSW to take genome analysis ‘offline’ by adapting the algorithms that perform DNA analysis to require far less compute than current tools.

Minimap2 makes sophisticated analysis possible on hand-held devices. Genome Media.

Medical practitioners fighting the Ebola and Zika viruses in New Guinea and Brazil have already used small genome sequencing devices that can clip on to a smartphone, but these devices still require high-performance computer workstations or reliable internet connections to identify genes.

Devices like the Oxford Nanopore Technologies MinION can create over a terabyte of data in 48 hours, but their use still isn’t commonplace because comparing or ‘aligning’ DNA from an unknown sample to a reference database to figure out what the sample is requires around 16 GB of RAM, which is beyond the capabilities of most mid-range laptops and flagship smartphones.

For cash-strapped medical programs in developing countries or during large-scale outbreaks, that kind of processing power isn’t easy to come by at scale, and a reliable internet connection can be just as hard to find.

In a new paper released in Nature, Garvan’s Genomic Technologies lead Dr Martin Smith and his team detailed the computational method for reducing the amount of memory needed for aligning sequences from 11GB to 2GB - well within the reach of mid-range smartphones.

The researchers adapted the Minimap2 program, which aligns DNA sequencing ‘reads’ to a reference library of known genomes.


READ MORE …

Dante Labs starting first of it's new powerhouse sequencing clinic chain

Dante Labs Announces First European Clinic With Integrated 30X Whole Genome Sequencing in Standard Clinical Care

Dante Labs takes the first step of its ambitious project to integrate high coverage genome sequencing in clinical care in clinics and hospitals. 

Dante Labs has announced the first of hundreds of European clinics which will integrate whole genome and whole exome sequencing in standard clinical care, further making personalized medicine a standard within the European health care system.

Dante Labs starting first of it's new powerhouse sequencing clinic chain. Campotosto, L’Aquila, Italy

The clinic, "Villa Letizia," is located in L’Aquila, Italy, and is the selected destination for patients across the entire Mediterranean region. Patients will receive 100X whole exome or 30X whole genome sequencing with premium turnaround time and personalized reports as part of their standard clinical care.


READ MORE …

Cannabis Sequencing Tech

Segra Deploys Disruptive Cannabis DNA Sequencing Platform

March 04, 2019 12:05 ET Source: Segra International Corp.

Cannabis Sequencing Tech

VANCOUVER, British Columbia, March 04, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. (“Segra” or the “Company”), a cannabis agritech company, is pleased to announce that its Genotyping and Molecular Lab Services Division (“GMLSD”) has installed and operationally qualified Nanopore-based sequencing for its Next Generation Sequencing (“NGS”) platform. NGS allows for the collection of large amounts of genetic data from cannabis samples. You put your weed in there.

READ MORE …

Early days for new MGI sequencing tech...

MGI Announces New Advanced Sequencing Chemistry (CoolNGS)

MGI's "Broadband" Sequencing Delivers Bandwidth to Achieve Genome for All Vision

Early days for new MGI sequencing tech

SAN JOSE, Calif., March 4, 2019 /PRNewswire/ -- MGI, a subsidiary of BGI Group, unveiled its novel CoolNGS chemistry, a disruptive new sequencing approach for its DNBseq™ sequencing technology that enhances the throughput, accuracy, read length and cost effectiveness of DNA sequencing.


READ MORE …

Genome sequencing "a waste of time for healthy people" claims NHS officials, missing the point

Genome sequencing for healthy dismissed as waste of time for UK project

Healthy people in the UK are to be controversially offered genetic testing by the National Health Service (NHS) – for a fee. The plan has stoked concerns among geneticists and clinicians, who question its clinical usefulness for healthy people and worry it could waste NHS resources.

Genome sequencing "a waste of time for healthy people" claims NHS officials, missing the point

UK health minister Matthew Hancock said seriously ill children and adults with genetic conditions will be offered the service for free, but healthy people will pay and have the option of having their DNA analysed by NHS scientists. This will help predict a patient’s risk of developing various conditions, he said.

READ MORE…